Company intelligence
Lunit Cancer Screening
About Lunit Cancer Screening
Conquer Cancer through AI. Lunit is a public company that develops medical AI software for cancer screening and treatment. Lunit AI can empower you to enhance diagnostic performance. Our AI for chest x-ray and 2D & 3D mammography has been validated through 100+ publications in peer-reviewed journals such as JAMA Oncology, Lancet Digital Health and Radiology, and is now in use in 3,500+ sites globally. < Lunit AI Suite for Radiology > • Lunit INSIGHT CXR, AI Solution for Chest X-ray • Lunit INSIGHT MMG, AI Solution for Mammography • Lunit INSIGHT DBT, AI Solution for Digital Breast Tomosynthesis • Lunit CXR Triage, AI solution for Chest X-ray Triage *emergency department use, available in the US only *If you are interested in Lunit Oncology, please visit Lunit Oncology’s LinkedIn page.
Verified activity
Signals from Lunit Cancer Screening
4 published signals
Presence & Recognition
Lunit Cancer Screening is participating in the inaugural BRiM Summit 2026, which is scheduled for September 15–17, 2026, at The University of Western Australia.
Reported by Lunit Cancer Screening
Research & Knowledge
Lunit Cancer Screening published the latest issue of the Squeeze, which digs into evidence, context, and real-world experiences behind breast imaging conversations, including AI coworker studies, automation bias studies, AI-stream insights, and 10 considerations for a future-ready screening ecosystem.
Reported by Lunit Cancer Screening
Research & Knowledge
Lunit Cancer Screening published a study evaluating whether Lunit INSIGHT MMG correctly localized lesions in interval cancer cases.
Reported by Lunit Cancer Screening
Presence & Recognition
Lunit Cancer Screening participated in the AOCR-SGCR 2026 event in Singapore.
Reported by Lunit Cancer Screening